Status:
UNKNOWN
Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Cancer
Insomnia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Determine who can benefit from additional follow-up by a professional and what type of help is most appropriate (need and expectation of patients in terms of support by a health professional)
Eligibility Criteria
Inclusion
- Adults patients,
- With a diagnosis of localized or metastatic cancer,
- During or after their treatment,
- In one of the following three cancer centres: Gustave Roussy (Villejuif), Montpellier Cancer Institute (Montpellier), and Léon Bérard Center (Lyon)
- With a significative score on the self-screening Insomnia Severity Index score (ISI ≥ 8)
- Able to readily read and understand French,
- Able to use informatic tools confidently and with Internet access,
- Who have signed the online consent form,
- Affiliated to a social security system or beneficiary of the same.
Exclusion
- Patient with a visual, hearing or cognitive disability that is incompatible with the study,
- Simultaneous participation in another study evaluating a treatment of insomnia,
- Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.
Key Trial Info
Start Date :
February 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2024
Estimated Enrollment :
322 Patients enrolled
Trial Details
Trial ID
NCT05977062
Start Date
February 25 2022
End Date
October 13 2024
Last Update
August 4 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Léon Bérard
Lyon, France, 69008
2
Institut de Cancérologie de Montpellier
Montpellier, France, 34090
3
Gustave Roussy
Villejuif, France, 94805